Satori Capital. Hapbee

Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...

Things that make you go mmmm. Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
Internet Stock Review

And We Have Our First Bitcoin Double.

Galaxy Digital (GLXY.TO, BRPHF) $12.85, $9.75. The story remains the same from exactly two months ago today. As...

Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.

Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.
Biotech Stock Review

Video: Okay, You Tested Positive for Corona, Now What?

https://youtu.be/vN30emwcNS4 Professor Roger Seheult,...
Hepion Pharma HEPA

News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.

Of course, approval news is the ultimate "as huge as it gets" news. But at this stage...
Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
Internet Stock Review

Is The Market Overvalued? Barron’s Round Table January 2000.

Interesting viewpoints ahead of the market drifting from near 12,000 to 7,000. Equivalent to Dow dropping to near 20,000 today.
dexamethasone, Hepion

Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...

Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Hapbee

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Hapbee Announces Additions to Advisory Board December 17, 2020 New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
HAPBEE

Hapbee (HAPB): The Netflix of Feelings

After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!